Transplants of mesenchymal stem cells can help patients with diabetes

According to a new study, patients with type 2 diabetes who are not overweight and have had the disease for less than ten years may benefit from therapy based on transplantation of mesenchymal stem cells derived from their own bone marrow.

Read more

Biopro Stem Technology Laboratory 03

Type 1 diabetes can be cured with a tiny implant device without inducing an immune response

A team of researchers led by endocrinologists and biomedical engineers from the University of Washington School of Medicine in St. Louis and Cornell University has successfully demonstrated the possibility of implanting β-cells in diabetic mice using a miniature device. After the transplant, the cells secrete insulin in response to blood sugar levels and do not require immunosuppressants.

Read more

БиоПро Выбор потребителя 2018 #02

For the first time successfully created a hybrid embryo consisting of human and monkey stem cells

Scientists from the United States have reported a breakthrough in the field of medicine – the creation of an embryo that is partly human and partly monkey. However, researchers talk about serious ethical issues that need to be addressed before the discovery can be used in practice.

Read more

Mesenchymal stem cell therapy can help patients with non-healing diabetic foot ulcers

The new stem cell therapy will make diabetes-related amputations a thing of the past, according to the results of the phase 1 clinical trial. The trial involved administering a cell preparation containing adult mesenchymal stem cells (MSCs) derived from the patients’ own fat to patients with type 2 diabetes with diabetic foot ulcers (DFU). The results showed that the treatment stimulated the regeneration of the blood vessels surrounding the DFUs and accelerated healing. However, there were no serious side effects.

Read more

To treat type-2 diabetic heart disease, only one injection is needed to activate the stem cells. 

Researchers have found one of the reasons why more than 50% of people with type 2 diabetes die from complications from cardiovascular disease. And more importantly, they may have found a therapeutic approach based on stem cell activation that solves this problem.

Read more

БиоПро Выбор потребителя 2018 #09

Identification of the main mechanisms of self-renewal and differentiation of intestinal stem cells promises new approaches to the treatment of diseases

Scientists from the Helmholtz Zentrum München, Germany, were able to describe in detail the pathways of intestinal stem cell differentiation. Understanding this process will help create specific early treatments for endocrine dysfunction and may also be a promising regenerative approach to diabetes therapy.

Read more

БиоПро Выбор потребителя 2018 #03

Organoids created to treat type 1 diabetes are invisible to the immune system

Using stem cells, researchers at the Salk Institute for the first time created clusters of pancreatic cells that produce human insulin and are able to avoid rejection by the immune system. After transplantation into mice, the clusters effectively controlled blood glucose levels throughout the life of the animals without the use of immunosuppressants.

Read more

БиоПро Выбор потребителя 2018 #01

Stem cells in combination with glaucoma medication promote diabetic wound healing

A new study has demonstrated the promise of a revolutionary approach in the treatment of trophic foot ulcers associated with diabetes. Scientists have shown for the first time that a bioengineered scaffold composed of human mesenchymal stem cells (MSCs) combined with a drug commonly used to treat glaucoma improved healing and reduced wound inflammation in diabetic mice by as much as 75% compared to controls.

Read more

Stem cell gene editing will help cure a rare form of hereditary diabetes

The results obtained by researchers from the University of Washington University School of Medicine in St. Louis showed that the CRISPR/Cas9 technology may be promising as a treatment for diabetes, especially forms caused by a single gene mutation, and may also be used in the future for some patients with more common forms diabetes, such as type 1 and type 2.

Read more

A more effective way to treat diabetes with stem cells has been discovered

The researchers efficiently convert human stem cells into insulin-producing cells, which helped stabilize blood sugar and functionally cure diabetes for nine months after transplantation to mice.

Read more